Currently the Government’s Tobacco and Vapes Bill is making its way through Parliament (it is currently at Committee Stage in the House of Commons). The Bill will have no impact on medical cannabis patients and industry (as “medicinal products” are exempted in the definitions). However, the Bill does contain provisions impacting businesses manufacturing and/or distributing […]
Read More
In today’s episode of the Cannabis Industry Podcast, we speak to Dr Callie Seaman, Co-Chair of the Cannabis Industry Council and Research Director of Aqualabs. Callie shares her experiences advocating for medical cannabis, her hopes for the cannabis industry, and her recent Contribution to Science Award at the Cannabis Industry Awards. Episode 2 can be […]
Read More
Responsibility for all medical cannabis policy and regulation should sit with the Department of Health and Social Care (DHSC), according to the Cannabis Industry Council (CIC). In a submission to the Government’s Change NHS consultation, the CIC has urged for Home Office powers on licensing, importation, research, and scheduling to be transferred to the DHSC. […]
Read More
The Cannabis Industry Podcast, created by the Cannabis Industry Council, speaks with experts within the UK cannabis industry to chart the vision for the industry’s future. Join us in each episode as we explore how the transformative potential of cannabis can be realised. In today’s episode, we speak to Mike Morgan-Giles, CEO of the Cannbis […]
Read More
Two well-deserving industry champions were recognised at the inaugural Cannabis Industry Awards Dinner last week. The results, which were decided by public vote, were as follows: Contribution to Science Winner: Dr Callie Seaman (Aqualabs) Runner-up: Dr Mikael Sodergren and Simon Erridge (Curaleaf / Imperial College) Third place: Dr Simon Tordoff (CB1 Medical) Contribution to Social […]
Read More
Almost eight in 10 patients (79%) say they prefer prescription cannabis medicines to illicit cannabis (21%), according to new research from the Cannabis Industry Council (CIC). Patients were also asked whether they preferred prescription or illicit cannabis based upon a range of factors, including cost, quality, product range, reliability of supply, medical effectiveness, fear of […]
Read More
The NHS is failing to prescribe cannabis flower medication to any patients, including those with conditions such as epilepsy, chronic pain, and cancer, according to new research from the Cannabis Industry Council (CIC). The CIC asked 152 NHS Foundation Trusts in England how many individuals they had prescribed cannabis flos (flower) to between 2019 and […]
Read More
Allowing medical cannabis to be prescribed on the NHS for chronic pain could save the state healthcare provider almost £4 billion annually, according to a new research study. The research found that when a patient was prescribed medical cannabis for chronic pain, instead of alternative treatments, this saved the NHS £729 each year, as well […]
Read More
A good practice guide for prescription cannabis clinics has been published by the Cannabis Industry Council (CIC). The guidance includes 10 principles of good practice, as well as five specific policies for clinics to implement. The aim of the good practice guide is to encourage ethical and responsible operations, build industry collaboration, and deliver improved […]
Read More
The “number of items for private prescribing of unlicensed cannabis-based medicines” increased from 6,137 in September 2021 to 22,431 in September 2023. That’s according to an NHS Business Services Authority response to a freedom of information request. Business of Cannabis report that this equates to an compound annual growth rate of 83%. However, the UK […]
Read More